Hooser S B, Beasley V R, Waite L L, Kuhlenschmidt M S, Carmichael W W, Haschek W M
Department of Veterinary Pathobiology, University of Illinois, Urbana.
Vet Pathol. 1991 Jul;28(4):259-66. doi: 10.1177/030098589102800401.
The morphologic effects of microcystin-LR (MCLR) were examined in vitro and in vivo to identify the specific cell type(s) affected and to characterize the actin filament changes occurring in hepatocytes. Male Sprague Dawley rats were used for all studies. For in vitro studies, hepatic cells were isolated by collagenase perfusion of liver, while parenchymal cells (hepatocytes) and nonparenchymal cells were prepared by pronase digestion and metrimazide gradient centrifugation. Cell suspensions and and primary hepatocyte monolayer cultures were treated with MCLR at doses up to 10 micrograms/ml; cultured hepatocytes were also treated with phalloidin or cytochalasin B at a dose of 10 micrograms/ml; and rats were treated intraperitoneally with MCLR at 180 mg/kg. Cultured hepatocyte preparations and frozen liver sections were stained with rhodamine-labeled phalloidin for filamentous actin. In cell suspensions, MCLR did not affect nonparenchymal cells but caused rapid, progressive, blebbing of the plasma membrane in hepatocytes. In cultured hepatocytes, MCLR caused plasma membrane blebbing as well as marked reorganization of actin microfilaments. These alterations were dose and time dependent. Cultured hepatocytes treated with phalloidin or cytochalasin B also showed extensive plasma membrane blebbing and actin filament alterations; however, actin filament changes were morphologically distinct from those induced by MCLR. In vivo, MCLR-induced hepatocyte actin alterations occurred at the same time as, or slightly preceded, histologic changes that began 30 minutes after dosing. These studies suggest that early MCLR-induced morphologic changes occurring both in vivo and in vitro are due to alterations in hepatocyte actin filaments.
对微囊藻毒素-LR(MCLR)的形态学效应进行了体内和体外研究,以确定受影响的特定细胞类型,并描述肝细胞中发生的肌动蛋白丝变化。所有研究均使用雄性Sprague Dawley大鼠。体外研究中,通过胶原酶灌注肝脏分离肝细胞,而实质细胞(肝细胞)和非实质细胞则通过链霉蛋白酶消化和甲泛葡胺梯度离心制备。细胞悬液和原代肝细胞单层培养物用剂量高达10微克/毫升的MCLR处理;培养的肝细胞还用剂量为10微克/毫升的鬼笔环肽或细胞松弛素B处理;大鼠腹腔注射180毫克/千克的MCLR。培养的肝细胞制剂和冷冻肝切片用罗丹明标记的鬼笔环肽染色以检测丝状肌动蛋白。在细胞悬液中,MCLR不影响非实质细胞,但会导致肝细胞质膜迅速、渐进性起泡。在培养的肝细胞中,MCLR导致质膜起泡以及肌动蛋白微丝的明显重组。这些改变具有剂量和时间依赖性。用鬼笔环肽或细胞松弛素B处理的培养肝细胞也显示出广泛的质膜起泡和肌动蛋白丝改变;然而,肌动蛋白丝的变化在形态上与MCLR诱导的不同。在体内,MCLR诱导的肝细胞肌动蛋白改变与给药后30分钟开始的组织学变化同时发生或略早于组织学变化。这些研究表明,体内和体外早期MCLR诱导的形态学变化是由于肝细胞肌动蛋白丝的改变。